Skip to content

Drug interactions

Basiliximab + Ustekinumab

Severity: Major

Basiliximab and Ustekinumab: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ustekinumab blocks IL-12/23 pathways and basiliximab blocks the IL-2 receptor on activated T cells. Combined use broadens immunosuppression and may increase the risk of serious infections.

What this interaction means in plain words

Basiliximab and Ustekinumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Basiliximab belongs to Miscellaneous; Ustekinumab belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Additive immunosuppression through IL-12/23 and IL-2 receptor blockade.

What to do

Avoid unless specialist-directed. If used together, monitor closely for infection.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Basiliximab and Ustekinumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Basiliximab with Ustekinumab?

MediHelp rates the interaction as major. Basiliximab and Ustekinumab can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ustekinumab blocks IL-12/23 pathways and basiliximab blocks the IL-2 receptor on activated T cells. Combined use broadens immunosuppression and may increase the risk of serious infections.

How serious is the interaction between Basiliximab and Ustekinumab?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid unless specialist-directed. If used together, monitor closely for infection.

What other medicines interact with Ustekinumab?

MediHelp also lists interactions of Ustekinumab with, for example, Bcg vaccine live, Typhoid vaccine live, Adalimumab. The full list is on the Ustekinumab page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in